Condition: Obscure Gastrointestinal Bleeding · Iron-Deficiency Anemia · Antithrombotic Therapy · Sponsor: Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec
This is a single-center, randomized pilot study evaluating the feasibility and safety of two management strategies for patients on antithrombotic therapy who present with obscure gastrointestinal bleeding (OGIB). Participants will be randomized to either repeated endoscopic evaluations or a conservative medical approach with limited testing. The study aims to assess whether conservative management yields similar clinical outcomes and quality of life compared to standard repeated endoscopic procedures. Results will inform the design of a larger trial and address the current lack of guidelines for managing recurrent iron-deficiency anemia in this patient population.
This description comes directly from the study's public registry record.
Marie-Claude Lehoux, Master · 819 697-3333 · marie-claude.lehoux@ssss.gouv.qc.ca
Éva Mathieu, PhD · 819-697-3333 · eva.mathieu@ssss.gouv.qc.ca
Always discuss trial participation with your own doctor first.
| Centre hospitalier affilié universitaire régional de Trois-Rivières | Trois-Rivières, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07089030